Therapy News and Research

RSS

WebToMed forms strategic partnership with BioTE Medical

BioTE Medical COO Dan DeNeui today announced a strategic partnership with WebToMed, a Chicago based digital medical marketing firm. BioTE Medical is a leading provider of bio-identical hormone pellet therapy.

1 Jun 2013

State highlights: Mo. Gov. worried tax cut bill raises prescription drug sales tax; deadline day for bonus for Fla. Medicaid docs

St. Louis Beacon: Nixon Says Tax Cut Bill Removes Missouri's Sales Tax Break For Prescription Drugs. Gov. Jay Nixon has upped the ante in his criticism of a broad-based tax cut bill awaiting his decision, saying Thursday that it removes a sales tax exemption for prescription drugs that will raise taxes for millions of Missourians. One sponsor of the bill says there's plenty of time for the legislature to correct what he deemed a drafting error (Rosenbaum, 5/30).

1 Jun 2013

New clinical trial may help reduce radiation dose for patients with HPV-positive oropharyngeal cancer

Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings will be presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology on Sunday, June 2.

1 Jun 2013

Study shows utility of cfDNA blood tests for breast cancer patients

Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.

1 Jun 2013

Saint Louis University extends search for new medicines to treat childhood diarrhea

A $750,000 grant to the Center for World Health and Medicine at Saint Louis University will extend the search for new medicines to treat childhood diarrhea, which is the second leading cause of death of young children worldwide.

1 Jun 2013

FDA grants 510k clearance to muscle and joint rehabilitation medical device

The Food and Drug Administration today granted 510(k) clearance to a muscle and joint rehabilitation medical device developed by OHSU Scientist Dr. Paul Cordo, Ph.D., and AMES Technology, Inc.

1 Jun 2013

Cytomegalovirus might accelerate the development of glioblastoma

A virus that infects most Americans but that usually remains dormant in the body might speed the progression of an aggressive form of brain cancer when particular genes are shut off in tumor cells, new research shows.

1 Jun 2013

New therapy for lung cancer produces manageable side effects

A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's on the market, according research that scientists at Fox Chase Cancer Center will present at the 49th Annual Meeting of the American Society of Clinical Oncology on Saturday, June 1.

1 Jun 2013

Food insecurity increases risk of death among injection drug users living with HIV/AIDS

Food insecurity increases the risk of death among injection drug users living with HIV/AIDS even when they are receiving life-prolonging antiretroviral therapy (ART), according to a new study involving Simon Fraser University.

1 Jun 2013

Study suggests bright light therapy may improve sleep and brain function post mild TBI

A new study suggests that bright light therapy may improve sleep, cognition, emotion and brain function following mild traumatic brain injury (TBI).

1 Jun 2013

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

A new partnership, first of its kind for both organizations, will see Roswell Park Cancer Institute and Jasco Pharmaceuticals, LLC collaborating to advance development of an investigational pharmacological therapy that shows promise for treating both solid-tumor cancers and hematologic malignancies.

1 Jun 2013

Researchers discover potential biomarkers to identify patients with head and neck cancer

Researchers from Fox Chase Cancer Center will present data at the 49th Annual Meeting of the American Society of Clinical Oncology on Saturday, June 1, which shows the discovery of potential biomarkers that may be used to identify patients with head and neck cancer whose tumors are unlikely to respond to treatment by the targeted therapy cetuximab-a type of monoclonal antibody.

1 Jun 2013

New clinical practice guidelines on sleep apnea, driving risk on non-commercial drivers

The American Thoracic Society has released new clinical practice guidelines on sleep apnea, sleepiness, and driving risk on non-commercial drivers.

1 Jun 2013

Findings could potentially lead to new drug therapy for Cushing disease

Cushing disease is a life-threatening disorder most commonly triggered by tumors, often benign, in the pituitary glands, resulting in excess production of adrenocorticotrophic hormone.

1 Jun 2013

Health care questions: Do medical homes improve outcomes? Is high tech worth the cost?

Joseph Ashwal, MD, knew a good deal when he saw one. … The program -- the Total Care and Cost Improvement Program -- has been a game-changer for Ashwal and his practice, Frederick Primary Care Associates, yielding more than a 20 percent increase in payments from CareFirst last summer for the group's success during 2011 in lowering spending by keeping patients out of the hospital and emergency departments.

1 Jun 2013

Nanoparticle-based immunotherapy for cancer

The German Research Foundation has established a new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" (CRC 1066) at Johannes Gutenberg University Mainz and the Max Planck Institute for Polymer Research (MPI-P).

1 Jun 2013

Study supports future possibility of personalized medicine for cervical cancer

Doctors at Washington University School of Medicine in St. Louis have shown that testing cervical tumors before treatment for vulnerability to chemotherapy predicts whether patients will do well or poorly with standard treatment.

1 Jun 2013

Theoretical mathematical models offer insights into therapeutic, prevention strategies for HIV

The first few hours to days following exposure to human immunodeficiency virus can be of critical importance in determining if infection occurs in a patient. But the low numbers of viruses and infected cells at this stage makes it very difficult to study these events in humans or animal models.

1 Jun 2013

Five studies on breast, colon and colorectal cancer to be presented at ASCO Annual Meeting

Agendia, a world leader in molecular cancer diagnostics, today announced that results from five studies focused on breast, colon and colorectal cancer will be presented at the upcoming American Society of Clinical Oncology Annual Meeting to be held May 31-June 4, 2013 at McCormick Place in Chicago.

1 Jun 2013

MannKind completes AFREZZA Phase 3 clinical study in patients with type 1 diabetes

MannKind Corporation today announced that all follow-up visits have been completed for the patients enrolled in Study 171, a Phase 3 clinical study of AFREZZA (insulin human [rDNA origin]) inhalation powder, an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's next-generation inhaler. MannKind expects to release data from this study later this summer.

1 Jun 2013

Therapy News and Research

WebToMed forms strategic partnership with BioTE Medical

State highlights: Mo. Gov. worried tax cut bill raises prescription drug sales tax; deadline day for bonus for Fla. Medicaid docs

New clinical trial may help reduce radiation dose for patients with HPV-positive oropharyngeal cancer

Study shows utility of cfDNA blood tests for breast cancer patients

Saint Louis University extends search for new medicines to treat childhood diarrhea

FDA grants 510k clearance to muscle and joint rehabilitation medical device

Cytomegalovirus might accelerate the development of glioblastoma

New therapy for lung cancer produces manageable side effects

Food insecurity increases risk of death among injection drug users living with HIV/AIDS

Study suggests bright light therapy may improve sleep and brain function post mild TBI

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

Researchers discover potential biomarkers to identify patients with head and neck cancer

New clinical practice guidelines on sleep apnea, driving risk on non-commercial drivers

Findings could potentially lead to new drug therapy for Cushing disease

Health care questions: Do medical homes improve outcomes? Is high tech worth the cost?

Nanoparticle-based immunotherapy for cancer

Study supports future possibility of personalized medicine for cervical cancer

Theoretical mathematical models offer insights into therapeutic, prevention strategies for HIV

Five studies on breast, colon and colorectal cancer to be presented at ASCO Annual Meeting

MannKind completes AFREZZA Phase 3 clinical study in patients with type 1 diabetes

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News